Roche

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. 

CEO
Thomas Schinecker
CEOThomas Schinecker
Employees
103,249
Employees103,249
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1896
Founded1896
Employees
103,249
Employees103,249

RHHBY Key Statistics

Market cap
311.07B
Market cap311.07B
Price-Earnings ratio
27.77
Price-Earnings ratio27.77
Dividend yield
1.80%
Dividend yield1.80%
Average volume
2.96M
Average volume2.96M
High today
$48.74
High today$48.74
Low today
$48.15
Low today$48.15
Open price
$48.19
Open price$48.19
Volume
421.03K
Volume421.03K
52 Week high
$49.20
52 Week high$49.20
52 Week low
$34.10
52 Week low$34.10

Stock Snapshot

The current Roche(RHHBY) stock price is $48.63, with a market capitalization of 311.07B. The stock trades at a price-to-earnings (P/E) ratio of 27.77 and offers a dividend yield of 1.8%.

As of 2025-11-26, Roche(RHHBY) stock has fluctuated between $48.15 and $48.74. The current price stands at $48.63, placing the stock +1.0% above today's low and -0.2% off the high.

The Roche(RHHBY)'s current trading volume is 421.03K, compared to an average daily volume of 2.96M.

In the last year, Roche(RHHBY) shares hit a 52-week high of $49.20 and a 52-week low of $34.10.

In the last year, Roche(RHHBY) shares hit a 52-week high of $49.20 and a 52-week low of $34.10.

RHHBY News

TipRanks 2d
Lineage Cell says first OpRegen development milestone under Roche pact achieved

According to a regulatory filing, as previously reported, in December 2021, Lineage Cell Therapeutics (LCTX) entered into a collaboration and license agreement...

TipRanks 2d
Lineage Cell’s OpRegen shows evidence of progress, says H.C. Wainwright

H.C. Wainwright reiterated a Buy rating and $9 price target on Lineage Cell Therapeutics (LCTX), saying the major breakout event the firm is looking for is visi...

24/7 Wall St. 3d
Roche Commits $50 Billion And Softbank Pledges $500 Billion For US Manufacturing To Avoid Trump Tariffs

Trump’s Tariffs Led These 2 Companies To Invest Billions in The US Quick Read Roche (RHHBY) committed $50B for US manufacturing and R&D facilities after Trump...

Roche Commits $50 Billion And Softbank Pledges $500 Billion For US Manufacturing To Avoid Trump Tariffs

Analyst ratings

48%

of 23 ratings
Buy
47.8%
Hold
30.4%
Sell
21.7%

More RHHBY News

TipRanks 7d
Roche announces EC granted conditional marketing approval of Lunsumio SC

Roche (RHHBY) announced that the European Commission, EC, has granted conditional marketing authorisation of Lunsumio subcutaneous, SC, for the treatment of adu...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.